Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report

We examined whether neuropsychiatric symptoms (NPS) interact with cerebrospinal fluid (CSF) biomarkers (amyloid-β(42) [Aβ(42)], tau, phosphorylated tau(181) [ptau(181)], tau/Aβ(42), and ptau(181)/Aβ(42)) of Alzheimer's disease pathology to predict driving decline among cognitively-normal older...

Full description

Saved in:
Bibliographic Details
Published in:J Alzheimers Dis
Main Authors: Babulal, Ganesh M., Stout, Sarah H., Head, Denise, Holtzman, David M., Fagan, Anne M., Morris, John C., Roe, Catherine M.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5555740/
https://ncbi.nlm.nih.gov/pubmed/28453487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170067
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items